Literature DB >> 27903442

Are microRNAs true sensors of ageing and cellular senescence?

Justin Williams1, Flint Smith1, Subodh Kumar1, Murali Vijayan1, P Hemachandra Reddy2.   

Abstract

All living beings are programmed to death due to aging and age-related processes. Aging is a normal process of every living species. While all cells are inevitably progressing towards death, many disease processes accelerate the aging process, leading to senescence. Pathologies such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, amyotrophic lateral sclerosis, Huntington's disease, cardiovascular disease, cancer, and skin diseases have been associated with deregulated aging. Healthy aging can delay onset of all age-related diseases. Genetics and epigenetics are reported to play large roles in accelerating and/or delaying the onset of age-related diseases. Cellular mechanisms of aging and age-related diseases are not completely understood. However, recent molecular biology discoveries have revealed that microRNAs (miRNAs) are potential sensors of aging and cellular senescence. Due to miRNAs capability to bind to the 3' untranslated region (UTR) of mRNA of specific genes, miRNAs can prevent the translation of specific genes. The purpose of our article is to highlight recent advancements in miRNAs and their involvement in cellular changes in aging and senescence. Our article discusses the current understanding of cellular senescence, its interplay with miRNAs regulation, and how they both contribute to disease processes.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Aging; Alzheimer’s disease; Oxidative-stress; Senescence; microRNA

Mesh:

Substances:

Year:  2016        PMID: 27903442      PMCID: PMC5357446          DOI: 10.1016/j.arr.2016.11.008

Source DB:  PubMed          Journal:  Ageing Res Rev        ISSN: 1568-1637            Impact factor:   10.895


  146 in total

1.  A set of miRNAs participates in the cellular senescence program in human diploid fibroblasts.

Authors:  R Faraonio; P Salerno; F Passaro; C Sedia; A Iaccio; R Bellelli; T C Nappi; M Comegna; S Romano; G Salvatore; M Santoro; F Cimino
Journal:  Cell Death Differ       Date:  2011-11-04       Impact factor: 15.828

2.  Profile of microRNAs in the plasma of Parkinson's disease patients and healthy controls.

Authors:  Lucía F Cardo; Eliecer Coto; Lorena de Mena; Renée Ribacoba; Germán Moris; Manuel Menéndez; Victoria Alvarez
Journal:  J Neurol       Date:  2013-03-30       Impact factor: 4.849

3.  Circulating miRNA profiles in patients with metabolic syndrome.

Authors:  Dwi Setyowati Karolina; Subramaniam Tavintharan; Arunmozhiarasi Armugam; Sugunavathi Sepramaniam; Sharon Li Ting Pek; Michael T K Wong; Su Chi Lim; Chee Fang Sum; Kandiah Jeyaseelan
Journal:  J Clin Endocrinol Metab       Date:  2012-10-02       Impact factor: 5.958

4.  Reduced expression of hsa-miR-27a-3p in CSF of patients with Alzheimer disease.

Authors:  Carlo Sala Frigerio; Pierre Lau; Evgenia Salta; Jos Tournoy; Koen Bossers; Rik Vandenberghe; Anders Wallin; Maria Bjerke; Henrik Zetterberg; Kaj Blennow; Bart De Strooper
Journal:  Neurology       Date:  2013-11-08       Impact factor: 9.910

5.  Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21.

Authors:  Frederick J Sheedy; Eva Palsson-McDermott; Elizabeth J Hennessy; Cara Martin; John J O'Leary; Qingguo Ruan; Derek S Johnson; Youhai Chen; Luke A J O'Neill
Journal:  Nat Immunol       Date:  2009-11-29       Impact factor: 25.606

Review 6.  Biology of cancer and aging: a complex association with cellular senescence.

Authors:  Claire Falandry; Marc Bonnefoy; Gilles Freyer; Eric Gilson
Journal:  J Clin Oncol       Date:  2014-08-20       Impact factor: 44.544

7.  MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins.

Authors:  Kasey C Vickers; Brian T Palmisano; Bassem M Shoucri; Robert D Shamburek; Alan T Remaley
Journal:  Nat Cell Biol       Date:  2011-03-20       Impact factor: 28.824

8.  Nuclear outsourcing of RNA interference components to human mitochondria.

Authors:  Simonetta Bandiera; Silvia Rüberg; Muriel Girard; Nicolas Cagnard; Sylvain Hanein; Dominique Chrétien; Arnold Munnich; Stanislas Lyonnet; Alexandra Henrion-Caude
Journal:  PLoS One       Date:  2011-06-13       Impact factor: 3.240

Review 9.  Aging-Induced Stem Cell Mutations as Drivers for Disease and Cancer.

Authors:  Peter D Adams; Heinrich Jasper; K Lenhard Rudolph
Journal:  Cell Stem Cell       Date:  2015-06-04       Impact factor: 24.633

10.  MicroRNA-29 induces cellular senescence in aging muscle through multiple signaling pathways.

Authors:  Zhaoyong Hu; Janet D Klein; William E Mitch; Liping Zhang; Ivan Martinez; Xiaonan H Wang
Journal:  Aging (Albany NY)       Date:  2014-03       Impact factor: 5.682

View more
  31 in total

1.  Novel MicroRNA-455-3p and its protective effects against abnormal APP processing and amyloid beta toxicity in Alzheimer's disease.

Authors:  Subodh Kumar; Arubala P Reddy; Xiangling Yin; P Hemachandra Reddy
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2019-06-08       Impact factor: 5.187

Review 2.  The role of synaptic microRNAs in Alzheimer's disease.

Authors:  Subodh Kumar; P Hemachandra Reddy
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2020-08-20       Impact factor: 5.187

3.  Senescence-associated miR-34a and miR-126 in middle-aged Indians with type 2 diabetes.

Authors:  Joyita Banerjee; Swagata Roy; Yogita Dhas; Neetu Mishra
Journal:  Clin Exp Med       Date:  2019-11-15       Impact factor: 3.984

4.  MicroRNA-455-3p as a potential peripheral biomarker for Alzheimer's disease.

Authors:  Subodh Kumar; Murali Vijayan; P Hemachandra Reddy
Journal:  Hum Mol Genet       Date:  2017-10-01       Impact factor: 6.150

Review 5.  Deciphering the role of microRNAs in mustard gas-induced toxicity.

Authors:  Neha Mishra; Komal Raina; Rajesh Agarwal
Journal:  Ann N Y Acad Sci       Date:  2020-12-10       Impact factor: 5.691

Review 6.  Molecular mechanisms and cardiovascular implications of cancer therapy-induced senescence.

Authors:  Ibrahim Y Abdelgawad; Karim T Sadak; Diana W Lone; Mohamed S Dabour; Laura J Niedernhofer; Beshay N Zordoky
Journal:  Pharmacol Ther       Date:  2020-12-01       Impact factor: 12.310

7.  MiR-34a suppression targets Nampt to ameliorate bone marrow mesenchymal stem cell senescence by regulating NAD+-Sirt1 pathway.

Authors:  Chenchen Pi; Cao Ma; Huan Wang; Hui Sun; Xiao Yu; Xingyu Gao; Yue Yang; Yanan Sun; Haiying Zhang; Yingai Shi; Yan Li; Yulin Li; Xu He
Journal:  Stem Cell Res Ther       Date:  2021-05-06       Impact factor: 6.832

8.  A prototypical non-malignant epithelial model to study genome dynamics and concurrently monitor micro-RNAs and proteins in situ during oncogene-induced senescence.

Authors:  Eirini-Stavroula Komseli; Ioannis S Pateras; Thorbjørn Krejsgaard; Konrad Stawiski; Sophia V Rizou; Alexander Polyzos; Fani-Marlen Roumelioti; Maria Chiourea; Ioanna Mourkioti; Eleni Paparouna; Christos P Zampetidis; Sentiljana Gumeni; Ioannis P Trougakos; Dafni-Eleftheria Pefani; Eric O'Neill; Sarantis Gagos; Aristides G Eliopoulos; Wojciech Fendler; Dipanjan Chowdhury; Jiri Bartek; Vassilis G Gorgoulis
Journal:  BMC Genomics       Date:  2018-01-10       Impact factor: 3.969

9.  Relationship between miR-21 and miR-182 levels in peripheral blood and gastric cancer tissue.

Authors:  Xiaodong Wang; Ran Wang; Fenghuan Li; Yuan Wu; Yu Liu; Wenfang Zhang
Journal:  Oncol Lett       Date:  2017-05-30       Impact factor: 2.967

10.  Identification of Circulating hsa-miR-324-3p and hsa-miR-331-3p Exchanges in The Serum of Alzheimer's Patients and Insights into The Pathophysiological Pathways.

Authors:  Maryam Heydari; Zohreh Hojati; Moein Dehbashi
Journal:  Cell J       Date:  2021-05-26       Impact factor: 2.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.